Pathogen: SARS-CoV-2

Gentile

Italy
|
2023-2023
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Infectious diseases unit
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab

Kautsch

Poland
|
2020-2023
  • Paediatric
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Ferro

Italy
|
2020-2022
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Immunomodulator
  • Steroids
  • Baricitinib
  • Dexamethasone
  • Methylprednisolone

Bernal

Spain
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Steroids
  • Dexamethasone

Giacomelli

Italy
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir

Karakoc

Türkiye
|
2020-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antibiotics

ISACS-COVID-19

Croatia Italy North Macedonia (Republic of) Romania Serbia
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antibiotic
  • Azithromycin

Palčić Marija

Croatia
|
2021-2022
  • Adults
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Tocilizumab

Mengato

Italy
|
2020-2022
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Huygens

The Netherlands
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Rotundo

Italy
|
2022-2023
  • Adults
  • Fragile population
  • Immunocompromised host
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab
  • Molnupiravir
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Nguyen

France
|
2021-2022
  • Adults
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Tixagevimab/Cilgavimab